These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 17203185)
1. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185 [TBL] [Abstract][Full Text] [Related]
2. Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Akahane T; Asada K; Tsujimoto T; Uemura M; Fukui H Oncol Rep; 2006 Jan; 15(1):155-9. PubMed ID: 16328049 [TBL] [Abstract][Full Text] [Related]
3. Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis. Noguchi R; Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Mitoro A; Tsujinoue H; Imazu H; Masaki T; Fukui H Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6038-45. PubMed ID: 14676130 [TBL] [Abstract][Full Text] [Related]
4. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339 [TBL] [Abstract][Full Text] [Related]
5. Combination of interferon and angiotensin-converting enzyme inhibitor, perindopril, suppresses liver carcinogenesis and angiogenesis in mice. Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y Oncol Rep; 2005 Mar; 13(3):491-5. PubMed ID: 15706423 [TBL] [Abstract][Full Text] [Related]
6. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression. Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718 [TBL] [Abstract][Full Text] [Related]
7. Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice. Yoshiji H; Yoshii J; Kuriyama S; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Kitade M; Yamazaki M; Fukui H Oncol Rep; 2005 Jul; 14(1):213-8. PubMed ID: 15944792 [TBL] [Abstract][Full Text] [Related]
8. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Yoshiji H; Kuriyama S; Kawata M; Yoshii J; Ikenaka Y; Noguchi R; Nakatani T; Tsujinoue H; Fukui H Clin Cancer Res; 2001 Apr; 7(4):1073-8. PubMed ID: 11309359 [TBL] [Abstract][Full Text] [Related]
9. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial. Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Yamazaki M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Fujimoto M; Uemura M; Fukui H Oncol Rep; 2011 Dec; 26(6):1547-53. PubMed ID: 21874260 [TBL] [Abstract][Full Text] [Related]
10. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma. Wang Z; Zhou J; Fan J; Qiu SJ; Yu Y; Huang XW; Tang ZY Clin Cancer Res; 2008 Aug; 14(16):5124-30. PubMed ID: 18698030 [TBL] [Abstract][Full Text] [Related]
11. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization. Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597 [TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo. Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824 [TBL] [Abstract][Full Text] [Related]
14. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692 [TBL] [Abstract][Full Text] [Related]
16. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer]. Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161 [TBL] [Abstract][Full Text] [Related]
18. The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression. Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Fukui H Oncol Rep; 2003; 10(5):1369-73. PubMed ID: 12883709 [TBL] [Abstract][Full Text] [Related]
19. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats. Yoshiji H; Kuriyama S; Noguchi R; Ikenaka Y; Yoshii J; Yanase K; Namisaki T; Kitade M; Yamazaki M; Asada K; Akahane T; Tsujimoto T; Uemura M; Fukui H Int J Mol Med; 2006 May; 17(5):899-904. PubMed ID: 16596278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]